Recombinant IL13 (Lebrikizumab Biosimilar) antibody

Catalog No. ABIN7676016

This Human Monoclonal antibody specifically detects IL13 (Lebrikizumab Biosimilar) in ELISA, BLI, FACS, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL13 (Lebrikizumab Biosimilar) antibody (ABIN7676016)

Target: IL13 (Lebrikizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL13 (Lebrikizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL13 (Lebrikizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-13 Reference Antibody (lebrikizumab)

Characteristics: Anti-IL-13 Reference Antibody (lebrikizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL13 (Lebrikizumab Biosimilar)

Target: IL13 (Lebrikizumab Biosimilar)

Alternative Name: IL-13 (Lebrikizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P35225